WBA logo

Walgreens Boots Alliance (WBA)

Profile

Full Name

Walgreens Boots Alliance, Inc.

Ticker Symbol

WBA

Exchange

NASDAQ

Sector

Healthcare

Industry

Pharmaceutical Retailers

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.walgreensbootsalliance.com

Employees

193000

Key Details

Price

$11.31(-0.70%)

Market cap

$9.78B(Mid cap)

Last Dividend

$0.25

TTM Dividend yield

4.42%

Annual revenue

$147.66B(+6.17% YoY)

Annual EPS

-$10.01(-180.39% YoY)

PE ratio

-

Next earnings date

Jun 27, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.31
    WBA price is $11.31

    30-Day Relative Volume

    1.39
    WBA 30-day relative volume is 1.39

    Price Performance

    Price Most recent change

    -0.7%
    WBA price was down -0.7% on Jun 20, 2025

    Price YTD change

    +21.22%
    WBA price is up +21.22% since January 1st

    Price 1-year change

    -28.73%
    WBA price is down -28.73% year-on-year

    Price 3-year change

    -71.24%
    WBA price is down -71.24% over the past 3 years

    Price Range

    Price All-time high

    $97.30
    WBA price is currently -88.38% below its historical high of $97.30

    Price 3-year low

    $8.08
    WBA price is currently +39.98% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.78B
    WBA market capitalization is $9.78 billion

    Market cap 3-year change

    -71.22%
    WBA market capitalization is down -71.22% over the past 3 years

    Market cap All-time high

    $105.60B
    WBA market capitalization is currently -90.74% below its historical high of $105.60 billion

    Market cap sector rank

    92.16%
    WBA market capitalization is higher than 92.16% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.17%
    WBA shares outstanding is up +0.17% year-on-year

    Shares Outstanding 3-Year Change

    +0.06%
    WBA shares outstanding is up +0.06% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.21
    WBA beta is 0.21

    200-day SMA

    $10.22
    WBA price is currently +10.67% above its 200-day simple moving average

    50-day SMA

    $11.13
    WBA price is currently +1.61% above its 50-day simple moving average

    RSI

    54.04
    WBA 14-day relative strength index is 54.04

    Volume

    1.39
    WBA 30-day relative volume is 1.39

    ATR

    $0.08
    WBA average true range is $0.08

    10-day Historical Volatility

    5.60%
    WBA 10-day historical volatility is 5.60%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.25
    WBA last dividend was $0.25 per share, with an ex-dividend date of November 18, 2024

    Next Dividend

    -
    WBA next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $1.23
    WBA annual dividend per share is $1.23

    Dividend per share Sector Rank

    50.59%
    WBA annual dividend per share is higher than 50.59% of companies in Healthcare sector

    Dividend per share 1-Year Change

    -35.94%
    WBA annual dividend per share is down -35.94% year-on-year

    Dividend per share 3-Year Change

    -34.57%
    WBA annual dividend per share is down -34.57% over the past 3 years

    Dividend yield

    Dividend yield

    10.88%
    WBA annual dividend yield is 10.88%

    Dividend yield Sector Rank

    92.86%
    WBA annual dividend yield is higher than 92.86% of companies in Healthcare sector

    Other

    Payout ratio

    -14.59%
    WBA annual payout ratio is -14.59%

    Dividends paid

    $1.26B
    WBA annual dividends paid is $1.26 billion

    Free cash flow

    -$363.00M
    WBA annual free cash flow is -$363.00 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $147.66B
    WBA annual revenue is $147.66 billion

    Revenue Analysts estimate

    $151.55B
    WBA annual revenue is currently -2.57% lower than the consensus analysts' forecast

    Revenue 1-year change

    +6.17%
    WBA annual revenue is up +6.17% year-on-year

    Revenue Sector rank

    99.1%
    WBA annual revenue is higher than 99.1% of companies in Healthcare sector

    EPS

    EPS

    -$10.01
    WBA annual earnings per share is -$10.01

    EPS Analysts estimate

    $1.67
    WBA annual earnings per share is currently -698.68% lower than the consensus analysts' forecast

    EPS 1-year change

    -180.39%
    WBA annual earnings per share is down -180.39% year-on-year

    EPS Sector rank

    13.06%
    WBA annual earnings per share is higher than 13.06% of companies in Healthcare sector

    Profit

    Gross profit

    $26.52B
    WBA annual gross profit is $26.52 billion

    Gross margin

    17.96%
    WBA annual gross profit margin is 17.96%

    Operating profit

    -$1.59B
    WBA annual operating income is -$1.59 billion

    Operating margin

    -1.08%
    WBA annual operating profit margin is -1.08%

    Net income

    -$8.64B
    WBA annual net profit is -$8.64 billion

    Net margin

    -5.85%
    WBA annual net profit margin is -5.85%

    Expenses

    Total expenses

    $149.25B
    WBA annual total expenses is $149.25 billion

    Operating expenses

    $28.11B
    WBA annual total operating expenses is $28.11 billion

    Cost of goods sold

    $121.13B
    WBA annual cost of goods sold is $121.13 billion

    Selling, general & administrative expenses

    $28.11B
    WBA annual SGA is $28.11 billion

    Depreciation and amortization

    $2.46B
    WBA annual depreciation & amortization is $2.46 billion

    Interest expense

    $482.00M
    WBA annual interest expense is $482.00 million

    Income tax

    $1.25B
    WBA annual income tax is $1.25 billion

    EBIT & EBITDA

    EBIT

    -$13.74B
    WBA annual earnings before interest & taxes is -$13.74 billion

    EBITDA

    -$11.28B
    WBA annual EBITDA is -$11.28 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $81.04B
    WBA annual total assets is $81.04 billion

    Non current assets

    $62.70B
    WBA annual long term assets is $62.70 billion

    Current assets

    $18.34B
    WBA annual total current assets is $18.34 billion

    Cash and cash equivalents

    $1.32B
    WBA annual cash & cash equivalents is $1.32 billion

    Accounts receivable

    $5.85B
    WBA annual accounts receivable is $5.85 billion

    Inventory

    $8.32B
    WBA annual inventory is $8.32 billion

    Liabilities

    Total liabilities

    $68.86B
    WBA annual total liabilities is $68.86 billion

    Long term liabilities

    $41.90B
    WBA annual total long term liabilities is $41.90 billion

    Current liabilities

    $26.95B
    WBA annual total current liabilities is $26.95 billion

    Accounts payable

    $14.08B
    WBA annual accounts payable is $14.08 billion

    Debt

    Total debt

    $32.85B
    WBA annual total debt is $32.85 billion

    Total debt 1-year change

    -2.03%
    WBA annual total debt is down -2.03% year-on-year

    Long term debt

    $28.96B
    WBA annual long term debt is $28.96 billion

    Short term debt

    $3.89B
    WBA annual short term debt is $3.89 billion

    Equity & Capital

    Shareholders equity

    $10.45B
    WBA annual stockholders equity is $10.45 billion

    Book value

    $10.45B
    WBA annual book value is $10.45 billion

    Retained earnings

    $23.35B
    WBA annual retained earnings is $23.35 billion

    Working capital

    -$8.62B
    WBA annual working capital is -$8.62 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $1.02B
    WBA annual cash flow from operations is $1.02 billion

    Cash from operations 1-year change

    -54.92%
    WBA annual cash flow from operations is down -54.92% year-on-year

    Cash from investing

    $1.88B
    WBA annual cash flow from investing activities is $1.88 billion

    Cash from investing 1-year change

    +160.7%
    WBA annual cash flow from investing activities is up +160.7% year-on-year

    Cash from financing

    -$538.00M
    WBA annual cash flow from financing activities is -$538.00 million

    Cash from financing 1-year change

    +39.35%
    WBA annual cash flow from financing activities is up +39.35% year-on-year

    CAPEX

    CAPEX

    $1.38B
    WBA annual capital expenditures is $1.38 billion

    CAPEX 1-year change

    -34.77%
    WBA annual capital expenditures is down -34.77% year-on-year

    Free Cash Flow

    Free cash flow

    -$363.00M
    WBA annual free cash flow is -$363.00 million

    Free cash flow 1-year change

    -357.45%
    WBA annual free cash flow is down -357.45% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    17.96%
    WBA annual gross profit margin is 17.96%

    Operating margin

    -1.08%
    WBA annual operating profit margin is -1.08%

    Net margin

    -5.85%
    WBA annual net profit margin is -5.85%

    ROA & ROE

    ROA

    -9.72%
    WBA annual return on assets is -9.72%

    ROE

    -42.47%
    WBA annual return on equity is -42.47%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    WBA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    WBA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.38
    WBA price to book ratio is 1.38

    PB ratio Sector rank

    47.91%
    WBA price to book ratio is higher than 47.91% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.06
    WBA price to sales ratio is 0.06

    PS ratio Sector rank

    3.43%
    WBA price to sales ratio is higher than 3.43% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $39.21B
    WBA enterprise value is $39.21 billion

    Enterprise value Sector rank

    96.62%
    WBA enterprise value is higher than 96.62% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -15.25
    WBA EV/EBITDA is -15.25

    EV/EBITDA Sector rank

    9.48%
    WBA EV/EBITDA is higher than 9.48% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.68
    WBA annual current ratio is 0.68

    Quick ratio

    0.37
    WBA annual quick ratio is 0.37

    Leverage

    Debt to equity

    0.91
    WBA annual debt to equity ratio is 0.91

    Interest coverage ratio

    -28.50
    WBA annual interest coverage ratio is -28.50

    Risk & Stability

    Piotroski F-Score

    4
    WBA piotroski f-score is 4

    Altman Z-Score

    1.62
    WBA altman z-score is 1.62

    Analyst ratings

    Recent major analysts updates

    Feb 28, 25 Deutsche Bank
    Sell
    Jan 31, 25 Truist Securities
    Hold
    Jan 16, 25 Truist Securities
    Hold
    Jan 15, 25 RBC Capital
    Sector Perform
    Jan 13, 25 Evercore ISI Group
    In-Line
    Jan 13, 25 B of A Securities
    Underperform
    Dec 4, 24 RBC Capital
    Sector Perform
    Oct 23, 24 Jefferies
    Hold
    Oct 22, 24 TD Cowen
    Buy
    Oct 17, 24 UBS
    Neutral

    Institutional Ownership

    Screeners with WBA included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    S&P 500 companies earnings calendar
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Walgreens Boots Alliance?
    • Does Walgreens Boots Alliance pay dividends?
    • What sector is Walgreens Boots Alliance in?
    • What industry is Walgreens Boots Alliance in?
    • What country is Walgreens Boots Alliance based in?
    • When did Walgreens Boots Alliance go public?
    • Is Walgreens Boots Alliance in the S&P 500?
    • Is Walgreens Boots Alliance in the NASDAQ 100?
    • Is Walgreens Boots Alliance in the Dow Jones?
    • When was Walgreens Boots Alliance's last earnings report?
    • When does Walgreens Boots Alliance report earnings?
    • Should I buy Walgreens Boots Alliance stock now?

    What is the ticker symbol for Walgreens Boots Alliance?

    The ticker symbol for Walgreens Boots Alliance is NASDAQ:WBA

    Does Walgreens Boots Alliance pay dividends?

    Yes, Walgreens Boots Alliance pays dividends. The last payment was $0.25, with an ex-dividend date on November 18, 2024

    What sector is Walgreens Boots Alliance in?

    Walgreens Boots Alliance is in the Healthcare sector

    What industry is Walgreens Boots Alliance in?

    Walgreens Boots Alliance is in the Pharmaceutical Retailers industry

    What country is Walgreens Boots Alliance based in?

    Walgreens Boots Alliance is headquartered in United States

    When did Walgreens Boots Alliance go public?

    Walgreens Boots Alliance's initial public offering (IPO) was on March 17, 1980

    Is Walgreens Boots Alliance in the S&P 500?

    Yes, Walgreens Boots Alliance is included in the S&P 500 index

    Is Walgreens Boots Alliance in the NASDAQ 100?

    No, Walgreens Boots Alliance is not included in the NASDAQ 100 index

    Is Walgreens Boots Alliance in the Dow Jones?

    No, Walgreens Boots Alliance is not included in the Dow Jones index

    When was Walgreens Boots Alliance's last earnings report?

    Walgreens Boots Alliance's most recent earnings report was on Apr 8, 2025

    When does Walgreens Boots Alliance report earnings?

    The next expected earnings date for Walgreens Boots Alliance is Jun 27, 2025

    Should I buy Walgreens Boots Alliance stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page